Results 91 to 100 of about 418,579 (155)

A mixed-methods evaluation of the quantitative and perceived impact of Brexit on UK oncology clinical trial initiation between 2011 and 2020. [PDF]

J Pharm Policy Pract
Arora M, Elliott S, Kilcoyne A, Bolodeoku J, El Baghdady A.   +4 more
europepmc   +1 more source

Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA/EMA. [PDF]

Clin Transl Sci
Handa T, Tanaka A, Shikano M, Wakao R.
europepmc   +1 more source

Italian healthcare professionals' real-world experience with immunization in children of non-European origin: the Vax4globe survey. [PDF]

Front Pediatr
Moschese V, Graziani S, Spadea A, D'Amore M, Mosco R, Ciampini S, Di Giorgio N, Arcano S, Ceccarelli S, Chianca M, Piccinini S, Polito A, Porcari M, Puliafito P, Silenzi R, Del Duca E, Piciocchi A, Pignata C, Miraglia Del Giudice M, Marseglia GL, Italian Society of Pediatric Research (SIRP) and the Italian Society of Pediatric Allergy and Immunology (SIAIP) Vaccine Committee.   +20 more
europepmc   +1 more source

Single Molecule Eu^2+/3+ Complex Platform for Optical and Magnetic Resonance Imaging In Vivo. [PDF]

J Am Chem Soc
Rodgers CB, Deal MP, Garman LC, Guzei IA, Allen MJ, Boros E.   +5 more
europepmc   +1 more source

Se eu fosse eu

, 2023
openaire   +1 more source

The EU AI Act: implications and compliance guidance for healthcare facilities. [PDF]

Front Digit Health
Dennstädt F, Hastings J, Windisch P, Jovanovic A, Marić TŽ, Brüningk S, Aebersold DM, Knopf A, Cihoric N.   +8 more
europepmc   +1 more source

Estimation of Future Patient Populations Eligible for Radioligand Therapies in the EU and the UK: A Modelling Study. [PDF]

Lancet Reg Health Eur
Holzwarth U, Cirillo R, Goulart M, Hernandez D, Peristeris P, Poschenrieder A, Papaioannou P, Kanavos P, la Fougère C, Schaetz L.   +9 more
europepmc   +1 more source

EU-HTA-Why Do Words Matter? [PDF]

J Mark Access Health Policy
Toumi M, Falissard B, Simoens S, Postma M, Wilk M, Boyer L, Bernardini R, Capri S, Espin J, Wasem J, Auquier P.   +10 more
europepmc   +1 more source

Controversies in EUS

Endoscopic Ultrasound, 2021
openaire   +3 more sources

Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses. [PDF]

J Prev Alzheimers Dis
Jessen F, Dell'Agnello G, Zimmer JA, Sapin C, Dichter S, Doty E, Epelbaum S, Evans CD, Hauck PM, Khanna R, Brooks DA, Sims JR, Agosta F, Alzheimer’s Disease Neuroimaging Initiative (ADNI).   +13 more
europepmc   +1 more source